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370a Tuesday, March 8, 2011(2.3 vs. 1.3 mM1s1) for both S1 and actoS1. The apparent maximum rate
constants of ATP binding to S1 and actoS1 (kmax) are similar for both
a and b (~160 s1 a- & b-S1, ~1400 s1 for a- & b-actoS1). The affinities
of ADP for S1 (a, 2.8; b, 0.5 mM) and for AM (a, 152; b, 21 mM) are much
tighter for b-S1. The ADP dissociation rate constants are also much slower
for b-S1 (2.7 vs. 0.9 s1 for S1 and >1200 vs. 84 s1 for actoS1). The ADP
release rate constant from AMD is of the right order to limit the shortening
velocity of the b isoform. For a-S1 the ADP release is too fast to measure
and faster than kmax of ATP induced dissociation of actoS1 and therefore not
limiting the contraction velocity. The affinity of both S1s for actin is tight (<
30 nM) and ADP weakens this more than 50 fold to 2.4 mM for a-S1 and
less than 5 fold for b-S1. Calculated cycle durations at physiological 5mM
ATP predict that both and spend ~20% of their contractile time actin-
bound, but have greatly different cycle times of ~6 vs. ~84 ms, respectively.
These isoforms are coexpressed in human heart so their diverse kinetics
likely lead to interesting dynamics in their cooperative contributions to car-
diac contraction.
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We used quantitative epi-fluorescence of mant-nucleotides to measure single
nucleotide turnovers in small bundles of permeable rabbit ventricle cells. In
relaxed cells nucleotide turnover occurs in two phases one with a short time
constant, 14 5 1 seconds, and a second with a much longer time constant,
144 5 10 seconds. The first is compatible with the normal relaxed state and
the second arises from myosin heads in the Super Relaxed State (SRX). Ap-
proximately 60% of the myosin heads were in the SRX. Recent work iden-
tified a similar state with a slow nucleotide turnover time constant, 230
seconds, in relaxed vertebrate skeletal muscle (Stewart et.al. PNAS, 2010).
The SRX appears to play a similar role in relaxed skeletal fibers and cardiac
cells providing a state with a very low metabolic rate. However, in active
fibers the properties of the SRX differ dramatically. There is a rapid transi-
tion of myosin heads out of the SRX in active skeletal fibers. In contrast, in
cardiac muscle, the population of myosin heads in the SRX is not changed
when the muscle, is activated. This property allows the SRX to play a very
different role in cardiac cells than in skeletal fibers. The mechanisms that
control cardiac contractility are complex, leading to an output that can
vary from highly active to very quiescent. The ability of myosin heads to
remain in the SRX, while other heads are generating tension, allows this
state to play a role in the regulation of cardiac output. In particular, the super
relaxed state could provide a mechanism for decreasing the metabolic load
on the heart, being cardioprotective, particularly in time of stress such as
ischemia.
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MyBP-C is a potent modulator of cardiac contractility and is localized to
two distinct regions (C-zones) flanking the myosin thick filament (TF)
bare zone. To determine whether MyBP-C modulates actomyosin motion
generation over the entire length of the TF or only within the C-zones,
we isolated native mouse ventricular TFs by mechanical and proteolytic dis-
persion. Negatively-stained EM images showed 1.6mm long TFs with defined
central bare zones. TFs contained intact MyBP-C, confirmed by western
blotting with domain specific antibodies. In a total internal reflectance mi-
croscopy based motility assay, TFs were imaged using fluorescent ATP
and the velocity of fluorescent shards of actin filaments was measured
over the entire length of TFs at 100 mM ATP and 20C. Four distinct veloc-
ities were observed, presumably corresponding to motion toward and away
from the bare zone, over regions with and without MyBP-C, the average ve-
locity of which was similar to that generated by monomeric myosin in the
motility assay (1.050.1mm/s). Limiting our analysis to bare zone directed
motility, actin moved at 1.850.1mm/s starting from the TF end and slowedabruptly to 1.050.1mm/s at 28558nm from the bare zone. In contrast, bare
zone directed motility on TFs from MyBP-C knockout mice demonstrated
only one velocity (1.750.1mm/s), equal to the faster velocity on wildtype
(WT) TFs, suggesting the slow velocity on the WT TFs is due to MyBP-
C. Similarly, only one bare zone directed velocity (1.950.1mm/s) was ob-
served on WT TFs after N-terminal proteolytic truncation of the MyBP-C
with calpain to within the MyBP-C motif (C1-C2 linker). We conclude
that the N-terminal domains of MyBP-C directly modulate actomyosin mo-
tion generation only in a ~285nm region of the thick filament, presumably
the C-zone, where MyBP-C is localized.
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Truncation mutations in cardiac myosin binding protein-C (cMyBP-C) are
prevalent causes of hypertrophic cardiomyopathy (HCM). Mounting evidence
suggest that truncated cMyBP-C causes HCM through haploinsufficiency.
Mouse models in which cMyBP-C is ablated (KO), or truncated, show varying
degrees of systolic and diastolic dysfunction and alterations in contractile kinet-
ics. Phenotypic variation observed in these models may, however, be related to
secondary adaptations and hypertrophic remodeling, rather than the direct
effect of cMyBP-C depletion.
In order to study the effects of cMyBP-C ablation on contractility in the absence
of hypertrophic remodeling, we produced engineered cardiac tissue (ECT) from
wild type (WT) and (KO) neonatal mouse cardiomyocytes.
Expression levels of several hypertrophic markers were similar in WT and KO
ECT, indicating a lack of hypertrophic remodeling. Contraction (50.051.1ms
vs. 42.951.9ms; p=0.002) and relaxation (41.350.8ms vs. 29.251.7;
p<0.001) times were significantly shorter in KO thanWT ECT. This difference
was more pronounced during relaxation, indicating a possible disconnect in
contraction-relaxation coupling. In order to investigate this possibility, we stud-
ied the 1st order derivative (dFdt) of the force tracings. We found no significant
difference in þdFdMax/-dFdtMax ratios (0.3850.02 vs. 0.4350.03; p=0.178),
indicating that cMyBP-C ablation does not directly affect contraction-
relaxation coupling. Elapsed times between þdFdtMax and peak developed
force (FMax) (27.350.8ms vs. 21.751.5ms; p=0.002), as well as between
FMax and -dFdtMax (36.551.6 vs. 18.452.1ms; p<0.001) was, however, sig-
nificantly shorter.
These findings indicate that cMyBP-C is involved in regulation of contractile
velocity and that its ablation shortens the period of sustained force production.
Our data indicates that previous reports of impaired relaxation and diastolic
dysfunction due to cMyBP-C KO depletion in mice and humans may be caused
by hypertrophic remodeling, rather than directly by cMyBP-C ablation/
haploinsufficiency.
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The function of troponin I (TnI) is essential to muscle contraction and heart
function. Three homologous TnI genes are present in vertebrate species en-
coding cardiac, fast and slow skeletal muscle TnI isoforms. In addition to the
core structure conserved in all TnI isoforms, cardiac TnI (cTnI) has an ~30
amino acids NH2-terminal extension. This segment is a regulatory structure
containing the b-adrenergic dependent protein kinase A (PKA) phosphoryla-
tion sites. The NH2-terminal extension of cTnI does not contain binding site
for other troponin subunits and is removable by restricted proteolysis to pro-
vide functional adaptation in stress conditions. The molecular mechanism for
the NH2-terminal modifications to regulate cTnI function is not fully under-
stood. In the present study, we tested a novel hypothesis that the NH2-termi-
nal extension may function through modulating the conformation and
activity of other regions of cTnI. Monoclonal antibody epitope analysis
and protein binding experiments demonstrated that deletion of the NH2-ter-
minal segment altered epitopic conformation in the middle region of cTnI,
similar to the effect of PKA phosphorylation. Such targeted long range con-
formational effect produced changes in the binding affinity for troponin T
and troponin C, with the later in a Ca2þ-dependent manner. These data sug-
gest that the NH2-terminal extension of cTnI regulates cardiac muscle
